An overview of the different excipients useful for the direct compression of tablets.
about
Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipientsData mining of solubility parameters for computational prediction of drug-excipient miscibility.Ultrasound-assisted powder-coating technique to improve content uniformity of low-dose solid dosage formsCo-processed chitin-mannitol as a new excipient for Oro-dispersible tabletsMicroencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation.Effects of highly hygroscopic excipients on the hydrolysis of simvastatin in tablet at high relative humidity.Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets.Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.A Review of Disintegration Mechanisms and Measurement Techniques.Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.Compressed orally disintegrating tablets: excipients evolution and formulation strategies.Challenges and emerging solutions in the development of compressed orally disintegrating tablets.A critical review on tablet disintegration.Sol-Gel Behavior of Hydroxypropyl Methylcellulose (HPMC) in Ionic Media Including Drug Release.The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants.A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral delivery of levodopa. Part II: characterization and formulation of an IPEC-based tablet matrix.Microstructure of Tablet-Pharmaceutical Significance, Assessment, and Engineering.Quality by design approach: antioxidant activity of the tablets containing cornelian cherry fruits in relation to their composition and physical properties.Tribo-electrification and Powder Adhesion Studies in the Development of Polymeric Hydrophilic Drug MatricesValeriana officinalis Dry Plant Extract for Direct Compression: Preparation and Characterization.Thermal Stability and Kinetic Study of Fluvoxamine Stability in Binary Samples with Lactose.Direct compression of cellulose and lignin isolated by a new catalytic treatment.Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin.Development, characterization and permeability assessment based on caco-2 monolayers of self-microemulsifying floating tablets of tetrahydrocurcuminModification of flow and compressibility of corn starch using quasi-emulsion solvent diffusion method.Terminalia gum as a directly compressible excipient for controlled drug delivery.Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.Applicability of UV laser-induced solid-state fluorescence spectroscopy for characterization of solid dosage forms.Development of agglomerated directly compressible diluent consisting of brittle and ductile materials.Method to study the effect of blend flowability on the homogeneity of acetaminophen.Formulation and evaluation of time-controlled triple-concentric mefenamic acid tablets for rheumatoid arthritis.Risedronate-loaded Eudragit S100 microparticles formulated into tablets.Reduction of tablet weight variability by optimizing paddle speed in the forced feeder of a high-speed rotary tablet press.Effect of Kollidon VA®64 particle size and morphology as directly compressible excipient on tablet compression properties.Development and evaluation of a miniaturized procedure for determining the bonding index: a novel prototype for solid dosage formulation development.Evaluation and prediction of powder flowability in pharmaceutical tableting.Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.Water droplet spreading and recoiling upon contact with thick-compact maltodextrin agglomerates.
P2860
Q28082369-461E430E-C844-469F-80B0-213652625435Q30620456-C19056B1-FF66-46AB-A2EB-4F0E2AFF9629Q34280218-22DCFF8C-122B-40A5-A5AE-00F2F2862EAFQ35591975-95664580-D16F-4149-B532-7469243CF248Q36779088-61C055F8-0500-479E-948C-D0134D9140DCQ36943776-2602098F-187D-42BF-8055-DFC68546FBDEQ37360741-85D9C62A-E436-4DB1-95B5-28DCD58144A4Q37712256-B8218D86-93C8-4D15-A16B-32DE4B0CFE69Q37739106-731C5B82-D708-4512-946B-E6A6FC52F31CQ38042442-571A865E-B9BE-447B-B626-6852EEC2066AQ38079606-4872DB76-3662-4A9E-A488-8736845C9BB1Q38232117-43922762-31E2-4C44-BDFB-91B27272BB07Q38480619-16CF40E0-7970-4863-99BA-618AC48FDEA1Q38616940-0366EB35-BD36-4855-AC7B-BF4F147F0E8EQ38664156-52E9F7E2-C969-4F44-B982-84C15BEA3C9AQ39265861-609B54D8-A37D-408C-9AE1-D346A15E3010Q39630255-64952AE5-7B49-44D4-8144-F0C2A75BF194Q40111332-0710DA3B-88FC-4A51-AE87-0243994FF803Q40992900-8B1C3992-FFD9-4EFD-BF4E-F8DA55899998Q41764221-758C6AFA-77D8-4F2E-BE2F-7923CF50B13AQ41870020-6E15A79B-6028-4707-B90D-620F5D1D0CEEQ41897285-049FECDF-6162-479B-85BA-41272F060B36Q41987485-84964FE5-EB28-4524-918A-F099DA86A5D9Q41987945-761E2F44-AD63-4BD2-B5FF-F5C4B019335CQ41988058-3430631B-3C12-4304-959A-1C7FB074096EQ42012010-59C8D84D-2B10-4ECA-918B-E19362B9E0FCQ42588805-ADD4052B-43F1-4E72-9E6B-8F58B2B5DB7CQ43263840-7DB27030-9875-4915-A94B-DC15A8A2A83EQ43767129-39FA24ED-5992-42F6-B5F4-F33EC0E07EBAQ44449443-41C2895E-6C6F-41F9-ABF4-FDD45100E024Q44926442-EB1C43E9-01B5-4B24-A795-26F081DE2DF0Q45340107-D06801EB-6102-4FFA-AB0B-9E169FEBF0FEQ46368292-1C58FB75-EB50-4766-951C-1EBCF24475DEQ47184695-4076EF0C-C36D-4C8A-B4D7-F3EAAEA38AA1Q47192597-43419F23-1F3D-48CB-B8EC-04CADB898ACEQ47711385-FA436790-52DE-4F1E-895C-5D0173255BEFQ48142419-30B2E943-CA52-465A-85FE-91556B8E8F06Q48612739-B7D77817-603A-4EEF-B4D1-11F1EC68EC88Q50455737-8DC7B66A-2804-4AEC-A9C6-EB51D8012E44Q51530235-93DFF4F4-B091-4C40-A553-4AE419957CA5
P2860
An overview of the different excipients useful for the direct compression of tablets.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
An overview of the different excipients useful for the direct compression of tablets.
@ast
An overview of the different excipients useful for the direct compression of tablets.
@en
type
label
An overview of the different excipients useful for the direct compression of tablets.
@ast
An overview of the different excipients useful for the direct compression of tablets.
@en
prefLabel
An overview of the different excipients useful for the direct compression of tablets.
@ast
An overview of the different excipients useful for the direct compression of tablets.
@en
P2093
P1476
An overview of the different excipients useful for the direct compression of tablets.
@en
P2093
Jivraj I I
Martini LG
Thomson CM
P356
10.1016/S1461-5347(99)00237-0
P577
2000-02-01T00:00:00Z